PE Focusing On Life Sciences Business Following Analytical Instrument Sale
This article was originally published in The Gray Sheet
Executive Summary
Four Perkin-Elmer "centers of excellence" will serve as the platform on which to build the company's $900 mil. PE Biosystems life sciences division - Applied Biosystems sequencing systems, Tropix high-throughput screening systems, PE Informatics and PerSeptive Biosystems.
You may also be interested in...
PE Biosystems DNA Analyzer Demand, Strong Sales Boost Stock 26% In Q3
Continued strong demand for the ABI Prism 3700 DNA analyzer, order growth across a broad range of additional products and release of financial results ahead of some analysts' estimates contributed to a 25.9% jump in PE Biosystems' stock price during the third quarter.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.